Indication
Illness Anxiety Disorder
1 clinical trial
2 products
Clinical trial
Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot StudyStatus: Recruiting, Estimated PCD: 2025-04-01
Product
FluoxetineProduct
Dextromethorphan